Modern understanding of the heterogeneity and differentiation pathways of lymphocytes has made possible a more rational classification of neoplastic disease of lymphoid cells. This approach has been adopted particularly by the groups at Kiel (Gerard-Marchant et al., 1974; Lennert, 1978) and the University of Southern California (Lukes & Collins, 1975) . As yet there have been few data published on the usefulness of these classifications in prospective clinical studies. In this paper we report the results of the use of the Kiel classification of non-Hodgkin's lymphoma. We show that this provides a useful means of distinguishing groups of patients with differing prognoses. However, it is clear from this study that symptomatic staging and, to a lesser extent other factors, give important additional prognostic information. We conclude that histopathological groupings are only some of a number of important factors which must be considered in planning the management of patients with this group of disease. presentation have been studied in 199 patients with non-Hodgkin's lymphoma (NHL) presenting to clinicians of the Oxford Lymphoma Group between January 1976 and April 1979. A further 10 patients were diagnosed with NHL but received no followup and have not been included. An additional 5 patients were lost during follow-up and were censored at the time they were last known to be alive. All other patients were followed until death or 1 September 1981. By this date 102 deaths (51%) had occurred. The median observation time was 39 months.
Eligibility
All new cases of non-Hodgkin's lymphoma including patients with chronic lymphocytic leukaemia (CLL), irrespective of age, were eligible for the study. Patients who had previous cytotoxic drug therapy or radiotherapy for lymphoma were not eligible.
Histological classification
This was based on the classification laid down by the Kiel convention of histopathologists. The histopathological groups recognised are shown in Table I together with the relative death rates for each group. Subdivision of the mixed centrocytic/centroblastic tumours into follicular, follicular plus diffuse and diffuse was attempted. However, extensive histological examination of all tissue available, including extranodal tissues, showed that the great majority of these patients fell 0 The Macmillan Press Ltd., 1983 0007-0920/83/010091-12 $01.00 The skin lymphoma group was a heterogeneous collection of patients, 5 with low grade lymphoma principally involving the skin and one with high grade lymphoma.
Large cell lymphomas which could not be readily classified as immunoblastic, centroblastic, lymphoblastic or of histiocytic origin were placed in an unclassified high grade lymphoma group. It is recognised that histiocytic tumours are not strictly lymphoid malignancies but they are included as a small group within this study. Clinical staging Conventional staging for spread identifying stages I-IV and IE-IIIE was used. Patients with malignant lymphoma lymphocytic have stage IV disease by definition and have been excluded from this staging analysis. Staging involved chest x-ray, skeletal survey examination of marrow particle sections from 3 sites. In patients with apparent stage I or II disease after these procedures lymphangiogram and liver biopsy were performed. Lymphangiogram was performed in other patients to help assess tumour load. Laparotomy was only performed in patients where disease was not demonstrable outside the abdomen. Patients with IE disease were defined as those with single site tumour not involving local nodes.
Symptomatic staging was based upon the Ann Arbor criteria (Carbone et al., 1971 . Some patients were also given local radiotherapy.
Immunoglobulin and acute phase protein quantitation was carried out using radial immunodiffusion against constant standards (Mancini et al., 1965) .
Bone marrow involvement was assessed using histological sections of bone marrow particles. In most cases particles were examined from the sternum and both iliac crests. Identification of tumour islands was facilitated by the use of immunoperoxidase staining for lysozyme to identify normal myeloid tissue.
Statistical methods employ Kaplan-Meier survival curves and differences between survival curves are assessed by log rank statistics (Peto et al., 1976 (Peto et al., , 1977 .
Results
Two factors, the histopathological group and the presence of systemic (B) symptoms, were found to be the most powerful determinants of prognosis and these exhibited considerable independence. After they were taken into consideration, other factors provided little additional information. Two notable exceptions were the improved survival of the patients with localised (Stage I or IE) disease and the poorer prognosis associated with elevated levels of C-reactive protein within the group of asymptomatic patients.
Histopathology
The distribution of patients according to the Kiel classification is shown in Table I survival time is only 4 months and these patients fare significantly worse than those with other high grade lymphomas (relative death rate 2.19, P=0.03). However, as the largest difference in survival relates to the simpler division of patients into those with high grade vs. low grade lymphoma (Figure 4 ), we will only consider this distinction when examining other factors.
Symptoms
The presence or absence of the following symptoms were noted in all patients: (i) Weight loss> 10% over 6 months or less (ii) Fever> 39°C or night sweats. Figures 5, 6 indicate how these symptoms related to survival. If patients with either (i) or (ii) or both are said to have B symptoms and all other are said to be asymptomatic, asymptomatic patients fare better than patients with B symptoms.
The importance of the division according to symptoms remains after correction for histopathological group. Figure 6 shows that among patients with low grade lymphomas, those in the asymptomatic group fared significantly better than those with symptoms (x2= 10.10, P=0.002). This difference occurs also among high grade lymphoma patients (x2-7.44, P=0.006) (Figure 6 ). The overall x2 for symptoms after correcting for pathology was 16 Time from entry (y) Figure 5 The effect of symptoms on survival. The profile labelled "systemic symptoms present" represents patients with B symptoms as classified in the text. The "symptoms absent" patients are all those without B symptoms. The numbers in brackets represent the total patients in each group. which is 54.9% of the uncorrected value. Also, the importance of pathology was not secondary to symptoms as the x2 for pathological grade was 9.0 after correcting for symptoms which was 39.6% of the uncorrected value. Thus symptoms and pathology are 2 relatively independent predictors of survival and with them we can establish 4 subgroups of patients whose survival is shown in Figure 6 . Asymptomatic low grade lymphoma patients survive longest, symptomatic low grade lymphoma and asymptomatic high grade lymphoma fare about equally and symptomatic high grade lymphoma patients do least well. In the sequel we will consider which factors can provide further prognostic information after this initial subdivision.
Stage
The relevance of stage of the disease has been studied in the 151 patients whose diagnosis was not malignant lymphoma lymphocytic (including chronic lymphocytic leukaemia). Patients with localised disease (Stage I and IE) fared better than remaining patients. As seen from Table II, patients with Stages II, III and IV had similar survival and the important factor here seems to be simply verification that the disease is restricted to one site. Localised disease was found in 23% of these 151 patients and, except for 2 cases, was associated with a lack of B symptoms. It will be seen from Table II that in high grade lymphoma the effect of symptoms is largely predictable by analysis of stage. Twenty of 65 (31%) asymptomatic patients with low grade lymphomas and 13 of 30 (43%) asymptomatic patients with high grade lymphomas presented with localised diseases and in each group this condition was associated with improved survival. Of the 15 patients with stage I high grade lymphoma, 9 are still in complete remission. They have follow-up times of 26, 29, 31, 36, 37, 43, 51, 55 and 60 months. Six of these patients had gastro-intestinal tumours and they were treated by surgical excision only. The remaining 9 patients received eradicative radiotherapy. Long-term remissions in relation to site in this group was seen in 4/6 gastro-intestinal, 3/5 nasopharyngeal, 0/1 testicular, 1/2 bone and 0/1 skin tumours.
Time from entry (y) Figure 6 The effect of B symptoms in different histopathological grades. LGL = low grade lymphoma. HGL= high grade lymphoma. Other numbers are the same as in Figure 3 . relatively poor prognosis. However, in the last 2 instances this relationship was secondary to the observation of symptoms. However, the predictive value of C-reactive protein was not lost after correction for symptoms and histopathology (Table   IV ). Figure 7 shows that an elevated level of Creactive protein was found in 37% of asymptomatic patients and within that group was a strong predictor of short survival. In contrast, a high percentage of symptomatic patients had an elevated level, but within this group the observation was of little prognostic significance.
Age and sex
Male patients (54%) had significantly poorer prognosis (P = 0.02) (Table IV) . Patients over 60 years fared less well than younger patients and survival prospects were still further reduced in patients over 70 (P=0.003, trend). (Table IV) After correction for histopathological group and symptoms, a stronger gradient with age was apparent which was highly significant (P=0.0001, trend). Thus, within each sub-group age was an important factor and the corrected estimates of the effect were larger because older patients tended to present with better histology (usually M.L. lymphocytic).
Other haematological factors Depressed haemoglobin levels were associated with poorer survival (Table IV) . The importance of this factor was most apparent in the asymptomatic low grade lymphoma group where the 20 patients (19%) with levels below 11 g/dl had a death rate more than twice as high as the total group (2= 13.8, P =0.0002). Depressed haemoglobin levels led to only a slightly worse prognosis in the other sub-groups but the corrected overall difference in all patients was still highly significant (x2 = 11.7, P = 0.0006). No further increase in mortality rates could be seen in patients with a greater degree of anaemia (<8gdl-' or <lOgdl-'). Platelet counts < 150 x 109 1 were also a sign of poorer survival prospects (Table IV) . The predictive power of this variable was less than for haemoglobin levels (P=0.001), but the effects did Relative death-rates are indicated to show the magnitude of the predictive value of each minor prognostic factor. The overall death-rate is unity and sub-groups with values larger than one correspond to a poorer-than-average survival.
remain after correction for the major prognostic groups (P=0.006). An effect was seen in each of the 4 major sub-groups of patients.
The presence of neutropenia (<2 x I0'1-) or neutrophilia (>6x i091-') were both minor negative prognostic factors of about equal magnitude and in each case the strength of this variable was little changed upon correction for symptoms and pathological group (Table IV) .
While depressed lymphocyte counts were associated with a slightly worse prognosis, this effect was largely accounted for by differences in symptoms and/or pathology and was not quite significant (X2 = 3.54, P = 0.06) after correction for these factors (Table IV) . Nevertheless, the finding of lymphopenia frequently proved to be a strong diagnostic indicator leading to the subsequent confirmation of lymphoma. Neither the ESR nor polyclonal immunoglobulin levels were associated with prognosis.
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108 (54) 91 (46) 41 (21) 154 (79) 20 (11) 19 (10) 142 (79) 21 (12) 105 (59) 51 (29) 36 (27) 30 (22) Meusers et al. (1980) in a substantially larger group of patients. However, there is marked heterogeneity within the lymphoplasma cytoid group. All 6 patients in our study dying in the first year who had this type of tumour were deemed sufficiently ill to require immediate systemic chemotherapy. However, a number of the remaining 9 patients have remained well throughout the study with no treatment after initial diagnosis. This exemplifies the marked differences in disease activity within certain histopathological groups, which may be clinically rather than microscopically identifiable. The other subgroup deserving special mention comprises those patients who had lymphoblastic lymphoma. These had a very poor outlook compared with any other histopathological group. Although not reported in this paper, analysis by treatment of these patients indicated that they were given full doses of the intensive chemotherapy. Also 7 of the 8 patients who died did so because of advanced disease rather than from inter-current infections or other preventable problems. The poorer survival of these subgroups is in accordance with the findings of Meusers et al. (1979) . A small group of patients with exclusively centroblastic lymphoma was included in the high grade group. This was not sufficiently large to allow meaningful comparison with the other high grade groups. Meusers et al. (1980) found a markedly better survival in patients with centroblastic, compared with those with immunoblastic lymphoma. However, this reflects a poor survival in their patients with immunoblastic lymphoma compared to the group described in this paper. These differences in survival of patients with immunoblastic lymphoma may reflect differences in chemotherapy used by the two study groups. High grade lymphoma presenting with stage I disease carries a relatively favourable prognosis. These patients were treated either with surgical excision or biopsy excision combined with irradicative local radiotherapy. Nine of these patients are still alive and apparently disease-free. This would support the view that at least a proportion of high grade lymphomas originate in a static end cell which does not recirculate. The results in stage IE gastrointestinal high grade disease correlate well with those of the large retrospective study of Weingrad et al., (1982) . Bitran et al., (1977) ; Chen et al., (1979) and Levitt et al., (1980) have also emphasised the curability of localised high grade lymphoma after local treatment.
There is a relative lack of non-histopathological data in the evaluation of non-Hodgkin's lymphoma, but there are some points of interest when our data are compared with the results of other workers, (Bloomfield et al., 1967a,b; Cabanillas et al., 1978; Dumont et al., 1975; Brown et al., 1975; Portlock & Rosenberg 1977) .
In the study of haematological findings at diagnosis in 140 cases by Bloomfield et al. (1977) , the abnormalities in the blood did not correlate with survival in the absence of bone marrow involvement. Against this, the present study indicates that both high or low as opposed to normal neutrophil counts, low lymphocyte count, low platelet count and low haemoglobin are all associated with poor prognosis. With the exception of lymphocyte counts, and high neutrophil values, these associations remained apparent after adjustment for histopathology and symptoms and they would appear to provide useful secondary prognostic information. Our rate of detection of disease in the marrow in low grade lymphoma is somewhat lower than that of othet workers. This may have been due to the particle sectioning technique missing paratrabecular involvement, especially in follicle centre cell lymphomas. We have noticed this pattern in more recent studies where trephine biopsy technique has been used. However, the combination of multiple site aspiration and histological processing of particles in high grade lymphomas has produced a rate of detection comparable with results of other workers; (Dick et al., 1974; Rosenberg et al., 1975) . Thus it is felt that our failure to find a correlation between bone marrow involvement and prognosis in patients with Stage II-IV high grade lymphoma, is unlikely to be due to failure to detect disease.
It may be postulated that the presence of systemic symptoms and disturbances of the acute phase proteins is related to prognosis by way of bulk of disease. Although disease bulk is very difficult to assess, an attempt was made to divide patients into those who had bulky and non-bulky disease and this showed a slight correlation with a presence of symptoms. However, when symptomatic stage was considered, the presence or absence of bulk disease was of only marginal value. It must be concluded that it is easier to assess symptoms rather than extent of bulk disease and that the exercise is more valuable. The effect upon prognosis of the elevation of C-reactive protein in asymptomatic patients is important and suggests that it might be wise to group these patients with those who have systemic symptoms.
This analysis indicates that it is reasonable to divide patients according to grade of malignancy and the presence or absence of symptoms in the first instance and that treatment should be based upon this subdivision providing that the stage of disease is beyond stage I. Within the four strata produced by this analysis it seems reasonable to treat the low grade asymptomatic patients purely for local problems following the principles of Portlock & Rosenberg (1977) . Patients with low grade lymphoma and B symptoms will require active intervention. However, long-term results in this group with both combination and single agent chemotherapy have been disappointing (Portlock et al., 1976; McKelvy & Moon, 1977; Lister et al., 1978) . Patients with disseminated high grade lymphoma all require aggressive treatment as their disease is potentially curable (DeVita et al., 1975; Berd et al., 1975; McKelvy & Moon, 1977 
